Overview
In this role, you help Life Sciences clients navigate pricing, reimbursement and market access to unlock patient access and long-term value. You’ll work in a collaborative EY-Parthenon team on strategic topics from value propositions to pricing strategy and evidence planning. You contribute to analyses, synthesize findings into client-ready stories, and support engagements from design to delivery. The role offers exposure to cross-border teams and a chance to shape access strategies for innovative medicines.
Pay / Benefits
- flexible working
- career development
- FlexEY benefits
- holidays
- health and wellbeing
- insurance
Responsibilities
- Own analyses and project modules from question framing to outputs
- Conduct structured secondary research on disease areas, treatment pathways, competitors, health systems and payer requirements
- Support and conduct primary research with payers, clinicians, patients and other stakeholders
- Build qualitative and quantitative analyses (analogue benchmarking, pricing research, access archetypes, evidence-gap assessments, opportunity sizing)
- Synthesize evidence into insights, implications and client-ready stories, presentations and models
- Contribute to client meetings, interviews and workshops and present analyses clearly
- Collaborate across multidisciplinary and international teams and contribute to practice development and business development
Key requirements
- Bachelor’s degree or equivalent in Life Sciences, Health Economics, Health Policy, Economics, Business or related field
- Minimum 2 years’ relevant strategy or market access consulting experience or in pharma/biotech/medtech
- Experience in pricing, reimbursement, market access, value proposition, payer research, HTA or evidence strategy
- Strong qualitative and quantitative analytical skills; proficient with Excel and PowerPoint
- Clear communication and client engagement ability
- Curiosity and rigorous problem-solving
- Collaborative and client-facing mindset
- Attention to detail and structured thinking
- Pricing and reimbursement
- HTA and evidence strategy
- Payer research
…
